Stockreport

Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights

Aura Biosciences, Inc.  (AURA) 
PDF Positive Phase 2 End of Study Data with Bel-sar in Early-Stage Choroidal Melanoma; Ongoing Phase 3 CoMpass Trial Recently Received Authorization to Start Enrolling Patie [Read more]